Nuveen
PHVS icon

Nuveen’s Pharvaris PHVS Stock Holding History

Nuveen’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
12,654
-4,353
-26% -$132K ﹤0.01% 3331
2026
Q1 		$480K Hold
17,007
– – ﹤0.01% 2853
2025
Q4 		$472K Hold
17,007
– – ﹤0.01% 2898
2025
Q3 		$424K Buy
+17,007
New +$377K ﹤0.01% 2956

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Nuveen's PHVS Position: Q2 2026 in Review

Nuveen reduced its Pharvaris (PHVS) stake by 26% in Q2 2026, selling an estimated $132K and leaving 12,654 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #3331.

Nuveen first reported a position in PHVS in Q3 2025 and has held it in 4 quarters since. The position peaked at $480K in Q1 2026. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Nuveen held 12,654 shares of Pharvaris worth $438K as of Q2 2026.
  • Nuveen sold 4,353 Pharvaris shares in Q2 2026, an estimated $132K.
  • Pharvaris made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3331 holding.
  • Nuveen first reported a position in Pharvaris in Q3 2025 and has held it in 4 quarters since.
  • Nuveen's Pharvaris position peaked at $480K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.